Saturday, January 31, 2026

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

China’s BYD Cuts Back Production, Fueling EV Market Jitters

BYD is slowing production and cutting shifts amid falling sales, impacting stock performance and prompting aggressive pricing strategies.

China Pulls Off Mind-Control Milestone With Brain Chip Trial

China advances brain-computer interface technology with successful trials, enabling paralyzed patients to control devices using thoughts.

Tag: Dispute

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Altman vs. Musk Heats Up—OpenAI Plans ChatGPT-Powered X Competitor

OpenAI plans to develop a social media platform, intensifying tensions between Sam Altman and Elon Musk amid ongoing legal disputes.

Sandoz: Millions of Patients Denied Access to Affordable Enbrel Alternative

Sandoz has filed an antitrust lawsuit against Amgen to challenge patent practices blocking its biosimilar, Erelzi, from market entry.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.